Patel Gautam

Average Profitability
0.6%
Insider Buys Quantity
3
Insider Buys Sum
$799,573.34
Insider Sells Quantity
4
Insider Sells Sum
$2M

Insider Activity of Patel Gautam

According to the SEC Form 4 filings, Patel Gautam, being in a position of

  1. director at Amneal Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 240000 shares for $2M,
    over all time since 2020-03-02, has bought 200000 shares for $799,573, and sold 240000 shares for $2M.

The largest purchase of all time was on 2020-03-03 and amounted to 117889 shares of Amneal Pharmaceuticals, Inc. for $464,483.

The largest sale of all time was on 2025-03-03 and amounted to 80000 shares of Amneal Pharmaceuticals, Inc. for $712,000.

Biography of Patel Gautam

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,004,0004100

Comparison of Insiders on Amount of Buys and Sells

2025-03-03SaleAmneal Pharmaceuticals, Inc.
AMRX
director
80,000
0.0176%
$8.90$712,0000%
2025-02-03SaleAmneal Pharmaceuticals, Inc.
AMRX
director
80,000
0.0171%
$8.14$651,200+3.91%
2025-01-08SaleAmneal Pharmaceuticals, Inc.
AMRX
director
62,590
0.0135%
$8.01$501,346+5.46%
2025-01-02SaleAmneal Pharmaceuticals, Inc.
AMRX
director
17,410
0.0039%
$8.01$139,454+7.99%
2021-12-17PurchaseAmneal Pharmaceuticals, Inc.
AMRX
director
50,000
0.0331%
$4.21$210,500-22.01%
2020-03-03PurchaseAmneal Pharmaceuticals, Inc.
AMRX
director, 10 percent owner
117,889
0.0826%
$3.94$464,483+14.27%
2020-03-02PurchaseAmneal Pharmaceuticals, Inc.
AMRX
director, 10 percent owner
32,111
0.0213%
$3.88$124,591+9.55%
Total: 7
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.